Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

You may be eligible if

• Inclusion
• Pathologically proven gynecologic malignancy
• No prior cryosurgery or radiofrequency ablation, in target lesion
• Patient is able to give and sign study specific informed consent
• Measurable disease, according to RECIST criteria
• Laboratory parameters and appropriate clearance from anesthesia based on other medical co-morbidities for placement of fiducials; these would include CBC, basic metabolic panel, BUN, and creatinine
• \>= 4 weeks from previous treatment (chemotherapy or radiation) of malignancy
• ECOG performance status of 0-3 as this procedure is minimally invasive and considered palliative in these patients
• Exclusion
• Any patient with active connective tissue disease such as lupus or dermatomyositis is excluded
• Any patient with active Crohn's disease or active ulcerative colitis is excluded
• Major medical or psychiatric illness, which would prevent completion of treatment or interfere with follow-up is excluded